Medford, MA, United States of America

Aranda Rae Duan

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Novobiotic Pharmaceuticals, LLC. Active years: 2024-2026.


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Aranda Rae Duan: Innovator in Pharmaceutical Compositions

Introduction

Aranda Rae Duan is a notable inventor based in Medford, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that utilize teixobactin. With a total of 2 patents to his name, Duan's work is paving the way for advancements in medical treatments.

Latest Patents

Duan's latest patents focus on pharmaceutical compositions comprising teixobactin. The inventions provide formulations that are capable of preventing the gelation of teixobactin. These compositions include teixobactin and a pegylated phospholipid. Additionally, the patents outline methods for preparing these pharmaceutical compositions and methods for treating subjects using them.

Career Highlights

Aranda Rae Duan is currently associated with Novobiotic Pharmaceuticals, LLC, where he continues to innovate in the pharmaceutical sector. His work is instrumental in enhancing the efficacy of teixobactin-based treatments.

Collaborations

Duan collaborates with talented individuals in his field, including Ana Cristina Cadete Pires and Losee Lucy Ling. Their combined expertise contributes to the advancement of pharmaceutical research and development.

Conclusion

Aranda Rae Duan's contributions to pharmaceutical compositions demonstrate his commitment to innovation in medicine. His work with teixobactin is a testament to the potential of new treatments in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…